Chen G H, Ge Y J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Mar 20;30(6):446-448. doi: 10.13201/j.issn.1001-1781.2016.06.006.
Insomnia and OSAHS are the comorbid diseases among the most common sleep disorders with high incidence. They both interact with each other apart from combined symptoms, therefore are defined as co-occurring insomnia and obstructive sleep apnea(CIO). CIO causes more serious damage to patients than single insomnia or OSAHS does, resulting in complex clinical treatments. However, the traditional treatment of CIO aims at solely OSAHS or insomnia patients with poor efficacy and compliance. Therefore, further investigation is required to elucidate the clinical mechanism and to optimize concurrent treatment for OSAHS and insomnia.
失眠和阻塞性睡眠呼吸暂停低通气综合征（OSAHS）是最常见的、发病率高的共病性睡眠障碍。它们除了有合并症状外，还相互影响，因此被定义为共发性失眠和阻塞性睡眠呼吸暂停（CIO）。CIO对患者造成的损害比单纯失眠或OSAHS更严重，导致临床治疗复杂。然而，CIO的传统治疗仅针对OSAHS或失眠患者，疗效和依从性较差。因此，需要进一步研究以阐明其临床机制，并优化OSAHS和失眠的联合治疗。
